Cargando…
Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem
[Image: see text] The prevalence of infections caused by metallo-β-lactamase (MBL) expressing Gram-negative bacteria has grown at an alarming rate in recent years. Despite the fact that MBLs can deactivate virtually all β-lactam antibiotics, there are as of yet no approved drugs available that inhib...
Autores principales: | Tehrani, Kamaleddin Haj Mohammad Ebrahim, Martin, Nathaniel I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644712/ https://www.ncbi.nlm.nih.gov/pubmed/28820574 http://dx.doi.org/10.1021/acsinfecdis.7b00094 |
Ejemplares similares
-
Small Molecule Carboxylates Inhibit Metallo-β-lactamases
and Resensitize Carbapenem-Resistant Bacteria to Meropenem
por: Tehrani, Kamaleddin H. M. E., et al.
Publicado: (2020) -
Drug development concerning metallo-β-lactamases in gram-negative bacteria
por: Li, Xiuyun, et al.
Publicado: (2022) -
Aspergillomarasmine A inhibits metallo-β-lactamases by selectively sequestering Zn(2+)
por: Sychantha, David, et al.
Publicado: (2021) -
Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance
por: van Haren, Matthijs J., et al.
Publicado: (2021) -
Mechanistic Investigations of Metallo‐β‐lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition
por: Wade, Nicola, et al.
Publicado: (2021)